A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

NCT07660432 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

472

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Malignant

Interventions

DRUG: SIM0689 for Injection

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.

Collaborators

[object Object]